Literature DB >> 34201947

SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.

Patrícia Moniz1, Sérgio Brito2, Pedro Póvoa1,3,4.   

Abstract

The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to underlying immune suppression of multiple causes, the impact on COVID-19 patients remains unclear. Furthermore, severe COVID-19 has recently been associated with significant immune suppression, and this may in turn impact CMV reactivation, possibly contributing to clinical course. Nevertheless, multiple confounding factors in these patients will certainly challenge upcoming research. The authors present a case series of five patients admitted to the intensive care unit (ICU) in the context of respiratory failure due to severe COVID-19. All patients evolved with CMV reactivation during ICU stay.

Entities:  

Keywords:  COVID-19; Cytomegalovirus; SARS-CoV-2; co-infections; critical care

Year:  2021        PMID: 34201947     DOI: 10.3390/jcm10132792

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  8 in total

1.  Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients With COVID-19 Infection.

Authors:  Scott Schoninger; Yanina Dubrovskaya; Kassandra Marsh; Diana Altshuler; Prithiv Prasad; Eddie Louie; Scott Weisenberg; Sarah Hochman; David Fridman; Polina Trachuk
Journal:  Open Forum Infect Dis       Date:  2022-06-10       Impact factor: 4.423

2.  Co-infection of Klebsiella pneumonia, Cytomegalovirus, Aspergillus and Zygomycete in a patient with SARS-CoV-2.

Authors:  Mihan Pourabdollah Toutkaboni; Atousa Hakamifard; Zahra Abtahian; Arefeh Mirahmadian; Mohammad Rahdar; Mojtaba Mokhber Dezfuli; Payam Tabarsi
Journal:  Clin Case Rep       Date:  2022-07-11

3.  Cytomegalovirus Coinfection in Critically Ill Patients with Novel Coronavirus-2019 Disease: Pathogens or Spectators?

Authors:  Suhail S Siddiqui; Soumyadip Chatterjee; Ambuj Yadav; Nitin Rai; Avinash Agrawal; Mohan Gurjar; Geeta Yadav; Shantanu Prakash; Amit Kumar; Syed N Muzaffar
Journal:  Indian J Crit Care Med       Date:  2022-03

4.  Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality.

Authors:  Ilenia Gatto; Emanuela Biagioni; Irene Coloretti; Carlotta Farinelli; Camilla Avoni; Valeria Caciagli; Stefano Busani; Mario Sarti; Monica Pecorari; William Gennari; Giovanni Guaraldi; Erica Franceschini; Marianna Meschiari; Cristina Mussini; Roberto Tonelli; Enrico Clini; Andrea Cossarizza; Massimo Girardis
Journal:  Intensive Care Med       Date:  2022-05-18       Impact factor: 41.787

5.  Updates in Management of SARS-CoV-2 Infection.

Authors:  Robert Flisiak; Dorota Zarębska-Michaluk; Marta Flisiak-Jackiewicz; Piotr Rzymski
Journal:  J Clin Med       Date:  2022-07-31       Impact factor: 4.964

Review 6.  SARS-CoV-2 infection and lytic reactivation of herpesviruses: A potential threat in the postpandemic era?

Authors:  Jungang Chen; Jiao Song; Lu Dai; Steven R Post; Zhiqiang Qin
Journal:  J Med Virol       Date:  2022-07-22       Impact factor: 20.693

7.  Cytomegalovirus Reactivation in Critically-ill COVID-19 Patients

Authors:  Leyla Talan; İrem Akdemir Kalkan; Neslihan Defne Altıntaş; Fügen Yörük
Journal:  Balkan Med J       Date:  2022-06-16       Impact factor: 3.570

Review 8.  Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.

Authors:  Ranim El Baba; Georges Herbein
Journal:  Front Immunol       Date:  2021-09-08       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.